SYLVIA OKOJI: Open Payments
NPI 1366032260 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$388 in 20 payments from 7 companies in 2025. Trend: 2023 $143 · 2024 $563 · 2025 $388
Food & beverage: $388
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $123 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $86 |
| Lilly USA, LLC | 4 | $71 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $42 |
| Exact Sciences Corporation | 2 | $34 |
| Novo Nordisk Inc | 1 | $18 |
| Bausch Health US, LLC | 1 | $13 |
Products named: Kerendia, FARXIGA, AIRSUPRA, NEFFY, ZEPBOUND, Cologuard Collection Kit, MOUNJARO, BREZTRI.
Industry payments across CA — which companies pay providers there.
